Jaclyn Tilak

Associate

Print Options

Jaclyn Tilak

Select the sections which you would like to include in the PDF:

vCard

Overview

Jaclyn Tilak is an associate in the Litigation and Dispute Resolution Group at Goodmans. Her practice focuses on commercial litigation, with an emphasis on intellectual property disputes.

Jaclyn has been counsel on a number of cases involving the Patented Medicines (Notice of Compliance) Regulations, and patent validity and infringement. Jaclyn has appeared before the Federal Court and the Federal Court of Appeal.

Jaclyn is recognized as an “Associate to Watch” in the area of Intellectual Property: Litigation by Chambers Canada, as a “Rising Star” in IP by The Legal 500 Canada and IP Stars, and as “One to Watch” in Intellectual Property Law by Best Lawyers in Canada.

Featured Work

Jaclyn’s representative work includes acting for:
  • Takeda Canada v Apotex, 2024 FC 106 - Counsel to Apotex in the successful dismissal of a patent proceeding relating to the drug dexlansoprazole (used to treat heartburn), on the basis of invalidity and non-infringement.
  • AbbVie Corporation v. JAMP Pharma Corporation, 2022 FC 1209 – successful representation of JAMP in a judicial review application resulting in JAMP retaining its Notice of Compliance for its adalimumab product
  • Steelhead v. ARC Resources, 2022 FC 998 – successful representation of four defendants in a summary trial dismissing an action for alleged patent infringement
  • Teva Canada Innovation v. Pharmascience, 2020 FC 1158 – successful challenge to the validity of a patent related to a multiple sclerosis medication, on the basis of obviousness
  • Eli Lilly v. Apotex, 2020 FC 816 – successful challenge to the validity and infringement of a patent relating to the dose of an ED medication, on the bases of anticipation and obviousness
  • Eli Lilly v. Apotex, 2020 FC 814 – successful challenge to the validity and infringement of a patent relating to the process to make the active ingredient in an ED medication, on the bases of anticipation and obviousness
  • Evolution Technologies v. Human Care Canada, 2019 FCA 209 – successful appeal of a trial judgment enjoining the sale of a major mobility-aid product and awarding financial remedies on account of patent infringement
  • Evolution Technologies v. Human Care Canada, 2019 FCA 11 – successful motion to stay a trial judgment enjoining the sale of a major mobility-aid product and awarding financial remedies, pending the outcome of an appeal

Credentials

Professional Involvement

Jaclyn is an active member of the community and volunteers with Pro Bono Ontario, providing summary legal advice to Ontarians in need.

Professional Affiliations

  • Law Society of Ontario
  • The Advocates’ Society
  • Toronto Intellectual Property Group